Mounira Banasr

Title: Mounira Banasr: Innovator in Neurocognitive Health

Introduction

Mounira Banasr is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of neurocognitive health through her innovative research and inventions. Her work focuses on addressing neurocognitive decline associated with chronic stress, aging, and neurodegenerative diseases.

Latest Patents

Mounira Banasr holds a patent for her invention titled "Compositions and methods relating to use of agonists of ALPHA5-containing GABAA receptors." This invention provides methods and related compositions aimed at preventing neurocognitive decline. The methods are based on the use of alpha5-GABAA receptor agonists to slow or prevent harmful morphological changes in the dendrites of the hippocampus and prefrontal cortex. These changes can lead to functional decline and neurocognitive deficits.

Career Highlights

Mounira Banasr is affiliated with the Centre for Addiction and Mental Health, where she continues her research and development in neurocognitive health. Her work has garnered attention for its potential to improve the quality of life for individuals facing cognitive challenges.

Collaborations

Mounira has collaborated with notable colleagues, including Thomas D Prevot and Etienne Sibille, to advance her research and explore new avenues in the field of mental health.

Conclusion

Mounira Banasr's innovative work in neurocognitive health highlights the importance of research in preventing cognitive decline. Her contributions through her patent and collaborations are paving the way for future advancements in this critical area of health.